NewsCase StudiesEvents

GlaxoSmithKline investing in Greece

Also in the news...

Israel export control licensing data: 31 July 2025

Export control licensing management information for Israel

Trade and services regulations in Luxembourg

If you are a UK business providing services in Luxembourg, you will need to follow Luxembourg regulations about:

If you were living in Iceland before 1 January 2021

Information for British citizens moving to or living in Iceland, including guidance on residency, healthcare and driving.

UK sanctions guidance for Uzbek businesses

Information about UK sanctions and relevant local laws to support compliance of non-UK businesses operating in Uzbekistan.

Protecting Business Reputation When Entering Foreign Markets

Expanding into new international markets presents promising growth opportunities. However, such moves come with challenges, especially when it comes to maintaining and protecting a business’s brand reputation.

GlaxoSmithKline investing in Greece

Back to News

The leading UK pharmaceutical company, Glaxo Smithkline (GSK) announced new €2.2 million investment in Greece, at the British Residence.

This investment will enable secondary packaging for 4 over-the-counter products. This will take place at FAMAR’s facilities, in the context of a long-term cooperation between the two companies. Production is expected to begin before the end of the year and will reinforce the exporting capacity of GSK Greece, as 98% of the new production will be exported to 32 countries.

The Minister for Development, Costis Hatzidakis, opened the event alongside the host, the British Ambassador, John Kittmer, who said:

I am delighted that GSK, a great British company, has decided to increase its investment in Greece. This decision shows the importance of foreign direct investment to Greece’s future and the importance of Greece’s efforts to improve the business environment.

gov.uk

You are not logged in!

Please login or register to ask our experts a question.

Login now or register.